| Literature DB >> 9486503 |
D Adkins1, R Brown, L T Goodnough, H Khoury, W Popovic, J DiPersio.
Abstract
Conventional approaches to the treatment of recurrent mantle cell lymphoma (MCL) yield unsatisfactory results. We describe a patient with recurrent MCL in leukemic phase refractory to chemotherapy who was successfully treated with allogeneic bone marrow transplantation. At last follow-up 1 year post-transplant, the patient was in complete remission and had limited chronic graft-versus-host disease.Entities:
Mesh：
Year: 1998 PMID： 9486503 DOI： 10.1038/sj.bmt.1701044
Source DB: PubMed Journal: Bone Marrow Transplant ISSN： 0268-3369 Impact factor: 5.483